Clinical Trial Update: Recombinant Human Endostatin(Rh-endostatin) Combine With Radiotherapy in the Treatment of Hepatocellular Carcinoma(HCC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of recombinant human endostatin (rh-endostatin) with radiotherapy for hepatocellular carcinoma; current status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Recombinant human endostatin (rh-endostatin) (recombinant human endostatin)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN